Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bispecific”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00836654
What this trial is testing

Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group

Who this might be right for
EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast)Malignant Ascites
Neovii Biotech 258
Testing effectiveness (Phase 2)Study completedNCT01207388
What this trial is testing

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Amgen Research (Munich) GmbH 116
Early research (Phase 1)Study completedNCT04540796
What this trial is testing

JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Janssen Research & Development, LLC 147
Not applicableNot Yet RecruitingNCT07695896
What this trial is testing

Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Yanyan Liu 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03888105
What this trial is testing

Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

Who this might be right for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Regeneron Pharmaceuticals 515
Testing effectiveness (Phase 2)Looking for participantsNCT07151690
What this trial is testing

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

Who this might be right for
Systemic Light Chain Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China 21
Testing effectiveness (Phase 2)Study completedNCT05235542
What this trial is testing

A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Akeso 128
Testing effectiveness (Phase 2)Study completedNCT03406858
What this trial is testing

Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaProstate Carcinoma Metastatic in the Bone+2 more
Barbara Ann Karmanos Cancer Institute 15
Early research (Phase 1)Study completedNCT06585891
What this trial is testing

Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutaneously to Healthy Adults

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT03516591
What this trial is testing

AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndrome (MDS)
Amphivena Therapeutics, Inc. 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631208
What this trial is testing

Study of the Efficacy and Safety of a Bispecific Antibody, Teclistamab in Severe Rapidly Progressive Interstitial Lung Disease Associated With Anti-MDA5

Who this might be right for
Severe Rapidly Progressive Interstitial Lung Disease Associated With Anti-MDA5
Assistance Publique - Hôpitaux de Paris 24
Testing effectiveness (Phase 2)Study completedNCT03192202
What this trial is testing

AFM13 in Relapsed/Refractory Cutaneous Lymphomas

Who this might be right for
Lymphoma, T-Cell, Cutaneous
Ahmed Sawas 18
Early research (Phase 1)Active Not RecruitingNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 13
Not applicableEnrolling By InvitationNCT07499128
What this trial is testing

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Who this might be right for
Cytokine Release SyndromeNeoplasmsLymphoma+13 more
National Cancer Institute (NCI) 136
Large-scale testing (Phase 3)Looking for participantsNCT07173751
What this trial is testing

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Who this might be right for
Breast Neoplasms
BioNTech SE 558
Very early researchNot Yet RecruitingNCT07185477
What this trial is testing

A Single-arm Single-center Trial of Bridging GPRC5D/CD3 Bispecific Antibody Treatment With BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableLooking for participantsNCT07309497
What this trial is testing

Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)

Who this might be right for
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaCART TherapyBispecific Antibody+1 more
University of Zurich 208
Testing effectiveness (Phase 2)Looking for participantsNCT07158918
What this trial is testing

ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
ABL Bio, Inc. 65
Testing effectiveness (Phase 2)Study completedNCT07102706
What this trial is testing

Phase I Trial of GR1803 Injection in Patients With RRMM

Who this might be right for
Multiple Myeloma (MM)
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 76
Testing effectiveness (Phase 2)Looking for participantsNCT04634552
What this trial is testing

Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Hematological Malignancies
Janssen Research & Development, LLC 510
Next Page